Mallmann, Peter External Entity

Publications

Sort by

Selected publications

  • 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.  Lancet2007 Academic Article GET IT
    Times cited: 1057

Other